|
Volumn 30, Issue 6, 1998, Pages 351-356
|
Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood
a a a a a a
a
NONE
(Denmark)
|
Author keywords
Acute lymphoblastic leukemia; BMISDS; Child; Growth hormone; Leptin; Treatment
|
Indexed keywords
ASPARAGINASE;
CORTICOTROPIN;
GROWTH HORMONE;
GROWTH HORMONE BINDING PROTEIN;
LEPTIN;
MERCAPTOPURINE;
METHOTREXATE;
PREDNISONE;
SOMATOMEDIN BINDING PROTEIN 3;
SOMATOMEDIN C;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOLESCENT;
ARTICLE;
CANCER CHEMOTHERAPY;
CHILD;
CHILDHOOD CANCER;
CLINICAL ARTICLE;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
GROWTH HORMONE DEFICIENCY;
HUMAN;
HYPOGONADISM;
INTRATHECAL DRUG ADMINISTRATION;
MALE;
PRIORITY JOURNAL;
SKULL IRRADIATION;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
BODY HEIGHT;
CRANIAL IRRADIATION;
FEMALE;
FOLLOW-UP STUDIES;
GROWTH;
HUMAN GROWTH HORMONE;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
MALE;
|
EID: 0031971504
PISSN: 00981532
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1096-911X(199806)30:6<351::AID-MPO9>3.0.CO;2-D Document Type: Article |
Times cited : (76)
|
References (35)
|